July 24, 2016 4:29 PM ET

Diversified Consumer Services

Company Overview of University of Liverpool

Company Overview

University of Liverpool is an educational institution that offers undergraduate, post graduate, and online programmes in the fields of science, law, philosophy, psychology, music, architecture, and media. The institution is based in Liverpool, United Kingdom.

Liverpool,  L69 3BX

United Kingdom

Phone:

44 15 1794 2000

Key Executives for University of Liverpool

Chancellor
Age: 77
Director of Research
Director of Business Services
Compensation as of Fiscal Year 2016.

University of Liverpool Key Developments

The Medicines Patent Pool Inks Agreement with the University of Liverpool to Develop HIV Nanomedicines

The Medicines Patent Pool reported a collaboration with the University of Liverpool and a license for the university's Solid Drug Nanoparticle technology to accelerate the development of WHO-recommended antiretrovirals as nanomedicines. The agreement covers a territory of all 135 low- and middle-income countries and two high-income countries in Africa, where licensees based anywhere in the world will have the right to make, use and distribute lower cost ARVs based on SDN technology. Under the terms of the agreement, the University of Liverpool will develop nanoparticles of ARVs licensed to the MPP such as atazanavir, darunavir and lopinavir to improve their solubility and thus reduce dosage. The MPP and the University of Liverpool will engage with pharmaceutical partners for product development and industrial scale-up. The MPP will then sub-license the nano-formulated ARVs and facilitate competitive manufacturing to spur wide distribution of the new medicines in low- and middle-income countries.

Eisai to Commence Two Joint Research Programs Toward Development of New Antimalarial Medicines

Eisai Co., Ltd. entered into two joint research agreements for the development of new antimalarial medicines. The first of these agreements is a joint development program with the Liverpool School of Tropical Medicine and the University of Liverpool. Under this agreement, the three parties will conduct preclinical development of a new antimalarial candidate compound E209. Research so far has shown that E209 is rapidly acting and shows efficacy against all types of malaria parasites, which means that it could be effective in patients for whom artemisinin-based malaria treatments are ineffective due to resistance. The second agreement is a joint development program with the non-profit public-private product development partnership Medicines for Malaria Venture (Location: Geneva, Switzerland, "MMV"). Under this agreement, Eisai and MMV aim to ultimately identify antimalarial candidate compounds with novel mechanisms of action that will be effective against malaria parasites resistant to existing treatments, as well as prevent relapse and block transmission to mosquitoes. This involves the optimization of compounds developed by Eisai that inhibit the biosynthesis of glycosylphosphatidylinositol (GPI) necessary for the growth of malaria parasites, and of a hit series of compounds identified from Eisai's compound library through joint research with MMV.

University of Liverpool Announces Board Changes

The University of Liverpool's Institute of Irish Studies has appointed Professor Peter Shirlow as Director and Blair Chair. He will begin at the University in August, 2015, and described his new role as a wonderful opportunity and a privilege. Professor Shirlow takes up the joint position following the retirement of Professor Marianne Elliott in January, 2015. Since then, Head of Department Dr. Frank Shovlin has operated as Institute Acting Director. Dr. Shovlin will continue in this role until Professor Shirlow's arrival. Former Blair Chair, Professor Marianne Elliott, has retained a role at the University as an Emeritus and Honorary Professor.

Similar Private Companies By Industry

Company Name Region
7city Group Ltd. Europe
A Suit That Fits Ltd. Europe
A Tale Unfolds Ltd Europe
ABC123 Daycare Ltd. Europe
ABS Bodyshop Services Ltd. Europe

Recent Private Companies Transactions

Type
Date
Target
No transactions available in the past 12 months.
 

The information and data displayed in this profile are created and managed by Capital IQ, a Standard & Poor's company. Bloomberg.com does not create or control the content. For inquiries, please contact Capital IQ directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
NYC2012, Inc. United States
Bertelsmann AG Europe
Rush University United States
Citizens Budget Commission United States

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact University of Liverpool, please visit www.liv.ac.uk. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.